Correction: Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) - Part I: In Vitro Testing and Characterization.
作者信息
Momin Mohammad A M, Farkas Dale, Hindle Michael, Hall Felicia, DiBlasi Robert M, Longest Worth
机构信息
Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia, USA.
Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, 401 West Main Street, P.O. Box 843015, Richmond, Virginia, 23284-3015, USA.
出版信息
Pharm Res. 2024 Sep;41(9):1903. doi: 10.1007/s11095-024-03760-9.
Abstract
摘要
相似文献
1
Correction: Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) - Part I: In Vitro Testing and Characterization.更正：用于新生儿呼吸窘迫综合征（RDS）的新型干粉气雾剂合成肺表面活性剂产品的研发——第一部分：体外测试与特性分析
Pharm Res. 2024 Sep;41(9):1903. doi: 10.1007/s11095-024-03760-9.
2
Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) - Part I: In Vitro Testing and Characterization.新型干粉式人工合成肺表面活性剂产品治疗新生儿呼吸窘迫综合征（RDS）的研究进展——第一部分：体外测试与特性研究。
Pharm Res. 2024 Aug;41(8):1703-1723. doi: 10.1007/s11095-024-03740-z. Epub 2024 Aug 7.
3
Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) - Part II: In vivo Efficacy Testing in a Rabbit Surfactant Washout Model.新型干粉式人工合成肺表面活性剂产品治疗新生儿呼吸窘迫综合征（RDS）的研发 - 第二部分：在兔肺表面活性剂洗脱模型中的体内药效学测试。
Pharm Res. 2024 Sep;41(9):1827-1842. doi: 10.1007/s11095-024-03754-7. Epub 2024 Sep 5.
4
Aerosol delivery of dry powder synthetic lung surfactant to surfactant-deficient rabbits and preterm lambs on non-invasive respiratory support.在无创呼吸支持下，将干粉合成肺表面活性剂以气溶胶形式输送给表面活性剂缺乏的兔子和早产羔羊。
Gates Open Res. 2019 Mar 14;3:6. doi: 10.12688/gatesopenres.12899.2. eCollection 2019.
5
Efficacy, dose-response, and aerosol delivery of dry powder synthetic lung surfactant treatment in surfactant-deficient rabbits and premature lambs.干粉合成肺表面活性剂治疗表面活性物质缺乏兔和早产羔羊的疗效、剂量反应和气溶胶输送。
Respir Res. 2022 Apr 4;23(1):78. doi: 10.1186/s12931-022-02007-8.
6
Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.含蛋白质的合成表面活性剂与不含蛋白质的合成表面活性剂用于预防和治疗呼吸窘迫综合征的比较
Cochrane Database Syst Rev. 2009 Oct 7(4):CD006180. doi: 10.1002/14651858.CD006180.pub2.
7
A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.一项关于合成表面活性剂与小牛肺表面活性剂提取物预防新生儿呼吸窘迫综合征的多中心随机双盲对照试验。
Pediatrics. 1997 Jul;100(1):39-50. doi: 10.1542/peds.100.1.39.
8
Synthetic surfactants with SP-B and SP-C analogues to enable worldwide treatment of neonatal respiratory distress syndrome and other lung diseases.合成表面活性剂具有 SP-B 和 SP-C 类似物，可在全球范围内治疗新生儿呼吸窘迫综合征和其他肺部疾病。
J Intern Med. 2019 Feb;285(2):165-186. doi: 10.1111/joim.12845. Epub 2018 Nov 14.
9
Aerosol, chemical and physical properties of dry powder synthetic lung surfactant for noninvasive treatment of neonatal respiratory distress syndrome.干粉合成肺表面活性剂的气溶胶、化学和物理特性，用于治疗新生儿呼吸窘迫综合征的非侵入性治疗。
Sci Rep. 2021 Aug 12;11(1):16439. doi: 10.1038/s41598-021-95999-0.
10
Surfactant aerosol treatment of respiratory distress syndrome in the spontaneously breathing premature rabbit.表面活性剂气雾剂治疗自然呼吸早产兔呼吸窘迫综合征
Pediatr Res. 1996 Jun;39(6):953-7. doi: 10.1203/00006450-199606000-00005.
引用本文的文献
1
Development of CPAP Overlay Interfaces for Efficient Administration of Aerosol Surfactant Therapy to Preterm Infants.用于向早产儿高效给予气溶胶表面活性剂疗法的持续气道正压通气覆盖接口的研发
AAPS PharmSciTech. 2025 Jan 16;26(1):34. doi: 10.1208/s12249-024-02987-4.
Zotero 插件